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ABSTRACT
Objective To evaluate the impact of standardised
consultations on patients with osteoarthritis of the knee.
Design Open pragmatic cluster randomised controlled
trial.
Setting Primary care in France.
Participants 198 primary care rheumatologists, each of
whom had to include two consecutive patients who met
the American College of Rheumatology criteria for
osteoarthritis of the knee.
Interventions Standardised consultation was provided
during three goal oriented visits (education on
osteoarthritisandtreatmentmanagement;informationon
physical exercises; information on weight loss) or usual
care.
Main outcome measures Change in body weight and in
time spent on physical exercises (Baecke index) at four
months.
Results 336 patients were included (154 allocated to
standardised consultation and 182 to usual care). Nine
patients were excluded because of lack of baseline data
(standardisedconsultation,n=8;usualcare,n=1).Atfour
months, taking into account the clustering effect, the
decrease in weight was greater in the standardised
consultation group than in the usual care group (mean
−1.11 (SD 2.49) kg v −0.37 (2.39) kg; P=0.007). The
physical activity score was higher for the standardised
consultation group than for the usual care group (mean
0.20 (0.65) v 0.04 (0.78); P=0.013). The standardised
consultation and usual care groups did not differ in
secondary outcomes, except for global assessment of
diseaseactivity(0-10numericscale: mean −1.66(2.26)v
−0.90 (2.48); P=0.003) and pain level (0-10 numeric
scale: mean −1.65 (2.32) v −1.18 (2.58); P=0.04).
Conclusions A structured consultation programme for
patients with osteoarthritis of the knee resulted in short
term improvement in weight loss and time spent on
physical activity.
Trial registration Clinical trials NCT00462319.
INTRODUCTION
Osteoarthritisisamajorsourceofmorbidity,disability,
and loss of function in the general population.
1 In an
ageingpopulation,osteoarthritisofthekneeislikelyto
be of increasing concern. The guidelines for treatment
ofosteoarthritisofthe kneefromtheNationalInstitute
for Health and Clinical Excellence, the American
College of Rheumatology, and the European League
Against Rheumatism recommend non-drug
treatments,
2-5 including education of patients, social
support,physicalexercises,andweightloss.
6However,
despite these recommendations, such non-drug treat-
ments are not systematically offered to patients in
clinical practice. For example, less than half of obese
patients with osteoarthritis of the knee have been
advised by a healthcare professional to lose weight.
7-9
Managing a chronic disease such as osteoarthritis
requiresamodificationofpatients’behaviour;patients
need to be educated about the disease and to under-
standthepurposeofthetreatmentproposed.However,
providingsuchcomplexinterventionsistimeconsum-
ing and difficult to do in the context of short
consultations.
10-12 The lack of implementation of
guidelinesfor treating osteoarthritis isprobably linked
todifficultiesinprovidinginformationtopatientsonall
these important matters during a single consultation.
We aimed to test whether a new standardised
programme of goal oriented visits would give better
results in terms of weight management and physical
activity than would usual care among patients with
osteoarthritis of the knee.
METHODS
Design
We designed a multicentre pragmatic cluster rando-
mised controlled trial. The unit of randomisation was
care providers (rheumatologists), and the unit of
analysis was patients. This design allowed us to avoid
the risk of contamination that can occur in trials
assessing participative interventions such as education
1INSERM, U738, Paris; Universite ´
Paris 7 Denis Diderot, UFR de
Me ´decine, Paris; AP-HP, Ho ˆpital
Bichat, De ´partement
d’Epide ´miologie, Biostatistique et
Recherche Clinique, Paris, France
2Service de Rhumatologie, Centre
Hospitalier et Universitaire, Lille,
France
3Almirall, SAS, Paris
4INSERM CIC 202, France;
Universite ´ Franc ¸ois Rabelais
Tours, France; CHRU de Tours,
France; INSERM U717, Paris
5Service de Rhumatologie, Ho ˆpital
de la Conception, Marseille,
France
Correspondence to: P Ravaud,
INSERM U738,
Dptd’Epidémiologie,Biostatistique
et Recherche Clinique, Groupe
Hospitalier Bichat-Claude Bernard,
46rueHenriHuchard,75877PARIS
Cedex 18
philippe.ravaud@bch.ap-hop-
paris.fr
Cite this as: BMJ 2009;338:b421
doi:10.1136/bmj.b421
BMJ | ONLINE FIRST | bmj.com page 1 of 9if healthcare providers are doing both experimental
and control interventions.
13-17 This study report fol-
lowed the guidelinesof the CONSORT statements for
cluster randomised controlled trials and non-drug
treatments.
18-20
Participants
Care providers were primary care rheumatologists
who, in France, are specialist doctors whom patients
can consult directly without referral. We recruited
rheumatologistsbymail,sendingthemaninvitationto
participate in the trial. If they were interested, they
responded by mail, and we then contacted them by
phone and gave them a more detailed explanation.
Each rheumatologist had to include the first two
patients who complied with the inclusion criteria.
Patientshadtomeetthefollowingcriteria:outpatient
aged 45-75 years consulting a rheumatologist, diag-
nosis of osteoarthritis of the knee according to the
American College of Rheumatology clinical and
radiological definition,
21 knee pain rated between
3 0m ma n d7 0m mo nan u m e r i c a ls c a l ea n d
necessitating treatment with non-steroidal anti-inflam-
matory drugs,body massindex ≥25and <35, and able
to understand and speak French and to answer
questions over the phone. These patients were
consulting a rheumatologist for the first time or were
already consulting a rheumatologist.
Weexcludedpatientswhoneededtohaveasurgical
procedureinthenextsixmonths;hadachronicdisease
such as coronary disease, severe hypertension, stroke,
congestive heart failure, chronic obstructive pulmon-
arydisease,type1diabetesmellitus,orrenalorhepatic
diseases; were unable to walk without aid; were
participating in another programme with nutritional
education;hadanelectronicimplantabledevice(pace-
maker); or were already participating in a clinical trial.
Allocation sequence generation
Werandomlyassignedrheumatologistswhoagreedto
participate to the intervention they had to provide:
usualcareorstandardisedconsultation.Astatisticianat
the department of epidemiology biostatistics and
clinical research, Hospital Bichat, who was not
involved in the conduct of the study, used a computer
generated process to randomise rheumatologists;
randomisation was stratified by region. If several
rheumatologists were working in the same clinic, they
were randomised to the same arm.
Allocation concealment
Webasedallocationonclustersratherthanindividuals
and concealed the sequence until interventions were
assigned.However,rheumatologistsrecruitedpatients
after knowing the treatment assignment. To limit the
risk of selection bias, we asked rheumatologists to
include the first two patients who met the selection
criteria. Furthermore, we investigated the risk of
selection bias and took it into account in the statistical
analyses.
Intervention
In each arm, interventions were provided at the
individual level. A group of rheumatologists and
epidemiologists developed and defined the experi-
mental intervention after iterative discussion
sessions.
22 The group defined the key components of
the intervention, the potential barriers to changing
practice,themainmethodstoovercomethesebarriers,
andthemainmanagementstrategiestobeconveyedto
the patients.
23
Thebackgroundbehindtheinterventionwasbriefly
as follows. Education about osteoarthritis, exercise
regimens, and weight loss has been independently
evaluated in randomised controlled trials (mainly
explanatory randomised controlled trials) and shown
toimprovetheconditionofpatientswithosteoarthritis.
Educatingpatientsaboutthesedifferentcomponentsin
clinical practice is recommended. However, these
recommendations are difficult to implement because
this is a complex intervention that is time consuming
for physicians and supposes a high level of under-
standing and adherence by the patient. To overcome
these problems, we aimed to develop an intervention
thatwouldbeeasytoimplementforphysiciansandthat
could improve patients’ adherence.
Rheumatologists contacted (n=2100)
Randomised clusters (n=198)
Allocated to standardised
  consultation
    Clusters (n=93)
    Patients (n=154)
Allocated to usual care
  Clusters (n=105)
  Patients (n=182)
Did not agree to participate (n=1902)
Excluded clusters (n=7)
  No baseline data:
    Clusters (n=8)
    Patients (n=2)
  No patients included:
    Clusters (n=2)
Excluded clusters (n=1)
  No baseline data:
    Clusters (n=1)
    Patients (n=1)
Completed follow-up visit:
  Clusters (n=77)
  Patients (n=127)
Analysed:
  Clusters (n=86)
  Patients (n=146)
Excluded from analysis:
  Clusters (n=7)
  Patients (n=8)
Month 4
Completed follow-up visit:
  Clusters (n=98)
  Patients (n=168)
Analysed:
  Clusters (n=104)
  Patients (n=181)
Excluded from analysis:
  Clusters (n=1)
  Patients (n=1)
Month 4
Completed follow-up visit:
  Clusters (n=63)
  Patients (n=105)
Analysed:
  Clusters (n=86)
  Patients (n=146)
Excluded from analysis:
  Clusters (n=7)
  Patients (n=8)
Month 12
Completed follow-up visit:
  Clusters (n=75)
  Patients (n=130)
Analysed:
  Clusters (n=104)
  Patients (n=181)
Excluded from analysis:
  Clusters (n=1)
  Patients (n=1)
Month 12
Flow diagram of participants in the trial
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ventionintendedtolimitthenumberofactionspervisit
to a physician and has previously been tested in a
randomised controlled trial. This trial, done in Harare
(Zimbabwe), tested the hypothesis that a programme
consistingoffewbutmoreorientedvisitsinthefieldof
antenatal care would give better results than the
standard programme.
24
To improve physicians’ adherence to the guidelines,
we proposed to overcome the constraint of consultation
time, the main obstacle to effective patient-provider
communication. For this purpose, we proposed three
goalorientedvisits,withonecomponentofthecomplex
intervention being implemented at each visit. We
standardised the content of each visit by providing a
clear description of the content on the case report form.
To improve patients’ adherence, our theoretical
background was as follows. The first visit aimed at
informing patients about the disease and treatment. In
fact, properly informed patients are more likely to
adhere to treatment plans and lifestyle changes. The
next two visits focused on only one component each
(exercise and weight loss). This focus allowed for a
simplification of the message to improve patients’
comprehension and recall of information. Finally, we
implemented tailored counselling of patients to
increase the odds of achieving modification of beha-
viour: the exercise programme took into account
patients’ preferences, and the strategy for losing or
maintaining weight varied according to patients’
readiness to change.
Experimental intervention
Rheumatologists randomised to the experimental arm
had to provide a programme of three goal oriented
standardised consultations for each included patient.
To help the physician to implement the intervention,
the case report form fully described all information
necessary for each of the standardised consultations
(including the key messages to tell the patient). The
physician had to follow the case report form step by
step.
During the first visit (day 0), rheumatologists
providededucationandadvicerelatedtoosteoarthritis
and its treatment. During the second visit (day 15),
rheumatologists informed patients about how to
protect joints (movements to avoid) and the need for
physical exercise. They proposed a progressive exer-
ciseregimenconsistingofthreesessionsof30minutesa
week progressively increased to three sessions of
60 minutes a week of rapid walking or cycling
depending on the patient’s preference.
During the third visit (day 30), rheumatologists
educated patients about body weight and its influence
onosteoarthritisofthekneeandproposedastrategyfor
losing or maintaining weight. They told patients that
excess weight would influence their knee pain and the
progression of osteoarthritis, that the area of the joint
contact was approximately 3 cm
2 (1 cm
2 in cases of
meniscectomy), and that the force applied to the joint
when walking is equivalent to three times the person’s
weight. In the case of osteoarthritis of one knee, with
excess weight the risk of developing osteoarthritis of
theotherkneeattwoyearsis54%;otherwise,theriskis
14%. The risk of worsening bilateral osteoarthritis of
the knee is threefold that without excess weight.
Finally, rheumatologists had to implement the US
NationalInstitutesofHealthevidencebasedguidelines
for management of obesity, a practical patient centred
tool for organising information for weight loss
counselling.
25 This tool considers particularly the
patient’s state of readiness to change and intentions
regarding implementation. The tool is available at
www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf
and is summarised in the box.
In addition, specific documents providedto patients
includedinformationonosteoarthritisandabookletto
record weight and physical activities each week. To
ensure consistency in delivery and content of the
intervention, rheumatologists had to use a pre-printed
data collection form following algorithms proposed in
the National Institutes of Health guidelines to provide
thisstandardisedprogramme,usesimilarlanguageand
explanations at each step of the programme, and
provide specific leaflets to patients.
Control group
In France, patients with osteoarthritis of the knee
usually visit their rheumatologists every six or
12 months. In this trial, we asked rheumatologists
randomisedtothecontrolarmtoprovideusualcareto
their patients during three consecutive visits (the same
numberofvisitsastheexperimentalgroup).Attheend
of the study, we made all documents used in the
experimental arm available to these rheumatologists.
Identification, evaluation, and treatment of overweight
and obesity in adults
1) Assess obesity risk—Physicians should assess their
patients’ risk of obesity related conditions and identify
obesity related comorbidities and risk factors for
cardiovascular disease
2) Ask about readiness to lose weight—Rather than
assuming that all overweight patients are motivated to
begin a weight loss programme, clinicians should
determine whether their patients are motivated to lose
weight
3) Advise about designing a weight control programme—
Clinicians should advise patients who are ready and
motivatedtoloseweightaboutdesigningaweightcontrol
programmeindividuallysuitedtotheirneeds.Forpatients
who are not ready or motivated, clinicians should provide
counselling to maintain weight
4) Assist in establishing appropriate intervention—A
comprehensive lifestyle modification programme with
decreased energy intake through diet and increased
energyexpenditurethroughphysicalactivitiesconstitutes
an integral part of all intervention programmes for weight
loss
RESEARCH
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We left the prescription of paracetamol or non-
steroidal anti-inflammatory drugs, as well as all other
co-interventions, to the care providers’ decision.
Outcomes
To assess outcomes, rheumatologists evaluated all
patientswhoagreed to participate during clinical visits
atbaselineandatdays15,30,and120.Anindependent
data collector evaluated patients’ satisfaction and
knowledgeduringaphoneinterviewbeforetheclinical
visits at day 120. An independent data collector
evaluated long term outcomes at 12 months during a
phone interview.
Short term outcomes (four months)
Weevaluatedthe primaryshorttermoutcomesatfour
months at the level of the patient. These included
patients’ weight measured on a specific weighing
machine provided to the rheumatologists and time
spentonphysicalexercisesasmeasuredbythephysical
exercise in leisure subscale of the Baecke index (0-5
scale).
26-28
Secondaryoutcomesevaluatedduringthefollow-up
visits to the rheumatologist were pain on movement
duringthe48hoursbeforethevisitmeasuredona0-10
numericalscale;scoreontheFrench-Canadianversion
of the Western Ontario and McMaster Universities
osteoarthritis index (WOMAC) physical function
subscale(17items,fivepointLikert-typescaleversion,
total score ranging from 0 to 68; high scores indicate a
high degree of functional impairment); global assess-
ment of disease activity as measured on a 0-10
numerical scale; and physical and mental scores on
theMedicalOutcomesSurveyshortform12(SF-12),a
genericqualityoflifequestionnaire.
29Rheumatologists
asked patients to complete questionnaires, including
WOMAC, the Baecke index, and the SF-12, in the
seven days after the visit and to return them in a
stamped envelope to an independent structure in
charge of the trial. Secondary outcomes evaluated
during a standardised phone interview by an indepen-
dent data collector were patients’ satisfaction with and
knowledge of with their treatment as evaluated on a 0-
10 numerical scale.
Long term outcomes (12 months)
At 12 months, the patients’ outcomes collected by an
independent data collector by phone interview con-
cerned self reported weight, time spent on physical
exercises during the previous three months as mea-
suredbythephysicalexerciseinleisuresubscaleofthe
Baecke index,
2728 pain on movement during the 48
hours before the contact as measured on a 0-10
numericalscale,scoreontheFrench-Canadianversion
of the WOMAC physical function subscale, global
assessment of disease activity as measured on a 0-10
numerical scale, and SF-12 score.
29 Measurement of
patients’weightat12monthswasselfreportedandnot
standardised, whereas measurement of the primary
outcome (weight at four months) was standardised by
the use of identical weighing machines provided to
rheumatologists.
Adverse events
Physicians systematically recorded all adverse events
and classified severity according to the World Health
Organization classification. The investigators system-
aticallyreportedallsevereadverseeventsandassessed
the relation between intervention and adverse events.
Sample size
The main objective of this study was to evaluate the
impactofaprogrammeofstandardisedconsultationon
the two main outcomes: change in patients’ body
weight and change in time spent on physical exercises
asmeasuredbythephysicalexerciseinleisuresubscale
of the Baecke index at four months.
We took into account the cluster randomisation in
the sample size calculation by using the intracluster
correlation coefficient. Because we had two main
outcomes, α was 0.025. We lacked data on possible
intracluster correlation in this specific area, so we
assumedanintraclustercorrelationofρ=0.05, which is
compatible with intracluster correlation coefficients
seen for patients’ self reported outcomes in other
studies of chronic conditions and is probably
conservative.
30Wefixedtheclustersizetotwopatients
recruited by each rheumatologist.
For change in patients’ weight, we anticipated a
power of 90% to detect an expected absolute variation
of mean change in weight of 2 (SD 7.4) kg between the
usual care and standardised consultation groups with
α=0.025,so362rheumatologistswouldbeneeded.For
time spent on physical activities (the physical exercise
in leisure subscale of the Baecke index), we expected a
Table 1 |Demographic and clinical characteristics of patients with knee osteoarthritis at
baseline according to group. Values are mean (SD) unless stated otherwise
Characteristics
All patients
(n=327)
Standardised
consultation (n=146)
Usual care
(n=181)
Age (years) 64.3 (8.3) 63.9 (8.1) 64.6 (8.3)
No (%) male 83 (25.4) 34 (23.3) 49 (27.1)
Weight (kg) 82.6 (13.3) 84.1 (12.9) 81.4 (13.6)
Body mass index 30.7 (3.7) 31.2 (3.5) 30.2 (3.8)
PEL (0-5) 2.2 (0.9) 2.2 (0.8) 2.2 (0.9)
Median (interquartile range) delay
since beginning of pain (years)
4 (1-10) 5 (2-10) 4 (1-7)
Age at beginning of pain (NS 0-10) 57.9 (10.5) 56.5 (10.5) 59.1 (10.4)
Pain (NS 0-10) 5.6 (1.3) 5.5 (1.2) 5.6 (1.3)
Global assessment of disease status
(NS 0-10)
5.6 (1.5) 5.6 (1.5) 5.6 (1.5)
WOMACphysicalfunctionsubscale(0-
100)
30.1 (12.1) 30.3 (11.8) 29.9 (12.4)
SF-12 physical function subscale
(n=276)
35.2 (7.2) 35.5 (7.1) 35.0 (7.4)
SF-12 mental function subscale
(n=276)
42.4 (10.6) 43.3 (10.7) 41.6 (10.4)
NS=numerical scale; PEL=physical exercises in leisure subscale of Baecke index; SF-12=Medical Outcomes
Survey short form 12; WOMAC=Western Ontario and McMaster Universities osteoarthritis index.
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groups. A total of 92 rheumatologists, with 184
patients, would be needed. To take into account these
two aims and the risk of imbalanced clusters, we
proposedtosample400rheumatologistsforthisstudy.
Each rheumatologist had to include two patients, for a
sample size of 800 patients.
Blinding
We could not completely blind patients and care
providers to the intervention allocated, and nor could
outcome assessment be blind. However, patients were
blinded to the study hypothesis. Patients were
informed that they were participating in a trial
comparing different forms of consultations. They
were informed about the content of the consultations
to which they were assigned but not the consultation
programme the other arm received. Data collectors
interviewing patients during the phone visits were
independent and blinded to treatment. However,
rheumatologists evaluating weight were not blinded
to treatment assignment.
Statistical methods
A blinded statistician at the Department of Epidemiol-
ogy Biostatistics and Clinical Research, Hospital
Bichat did the statistical analysis with SAS 9.1.
Analyses followed a pre-specified plan based on the
principle of modified intent to treat (that is, all
participants are included in the group to which they
were assigned, regardless of whether they completed
the intervention given to the group). However, if no
baseline data were recorded, we excluded the patients
from the analyses. Missing data were supplied by the
last observation carried forward procedure.
We analysed all outcomes in the framework of a
marginalmodelanalysis,comparingchangesinmeans
of variables in each group. We adjusted all compar-
isons for the baseline value of the considered outcome
and, except for weight, for the baseline value of the
body mass index. For the primary outcomes, we
considered a P value ≤0.025 to be statistically
significant. For secondary outcomes, we considered a
Pv a l u e≤0.05 to be statistically significant. We
restricted investigation of patients’ satisfaction and
knowledge at week four to patients who answered the
phone interview satisfaction questions.
We also did a propensity score analysis. For each
patient,wecalculatedtheconditionalprobabilitythata
patient received a particular treatment on the basis of
pre-treatment variables. The objective was to balance
the treatment groups so as to reduce bias from cluster
randomisation. We then derived a propensity score
weight: each patient was weighted with the inverse of
thepropensityscoreintheinterventiongroupandwith
the inverse of one minus the propensity score in the
control group. A propensity score weighted marginal
model was thus fitted to compare groups for each
outcome.
31
For each outcome measure, we estimated the intra-
cluster correlation coefficient and derived an approx-
imate 95% confidence interval by using formulas for
the balanced case.
32
RESULTS
Participants
The figure shows the flow of clusters and individual
participants through each stage. Because of difficulties
in recruitment, we included and randomised only 198
rheumatologists between May 2005 and June 2006;
137 rheumatologists included two patients, and 53
included only one patient. (We excluded six
Table 2 |Characteristics of treatments used by patients with knee osteoarthritis at baseline according to group. Values are
numbers (percentages)
Characteristics All patients (n=327)
Standardised consultation
(n=146) Usual care (n=181)
Drug treatments
Current use of analgesics 224/325 (68.9) 95/145 (65.5) 129/180 (71.7)
NSAIDs 184/326 (56.4) 90 (61.6) 94/180 (52.2)
Current use of NSAIDs 143/184 (77.7) 70/90 (77.8) 73/94 (77.7)
SYSADOA 142/326 (43.6) 68 (46.6) 74/180 (41.1)
Current use of SYSADOA 136/139 (97.8) 67/68 (98.5) 69/71 (97.2)
Intra-articular treatment 60 (18.3) 29 (19.9) 31 (17.1)
Non-drug treatments
At least one non-drug treatment 180/325 (55.1) 71 (48.6) 109/179 (60.2)
Diet 80 (24.5) 31 (21.2) 49 (27.1)
Consultation with a dietitian 19 (5.8) 7 (4.8) 12 (6.6)
Physical exercises at home 71 (21.7) 27 (18.5) 44 (24.3)
Physiotherapy 47 (14.4) 17 (11.6) 30 (16.6)
Knee orthosis 32 (9.8) 11 (7.5) 21 (11.6)
Insoles 35/326 (10.7) 11 (7.5) 24/180 (13.3)
Walking stick 23/325 (7.1) 10 (6.8) 13/179 (7.3)
NSAIDs=non-steroidal anti-inflammatory drug; SYSADOA=systematic slow acting drug for osteoarthritis.
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the standardised consultation group and one in the
usual care group) because they did not complete the
baselinedatafortheirpatientsandtwobecausetheydid
not include any patients). Consequently, at four
months, data were available for analysis for 327
patients—146 in the standardised consultation group
and 181 in the usual care group.
Tables 1 and 2 summarise the baseline character-
istics of patients in each group. The groups seemed to
be similar. However, the standardised consultation
group had a higher mean body mass index and longer
delay from the beginning of pain linked to osteo-
arthritis of the knee. Patients in the usual care group
were more often treated with non-drug treatments.
More than 95% of patients in the intervention group
and 96% of patients in the control group attended all
three consultations.
Outcomes
Table 3givestheresultsfortheprimaryandsecondary
outcome measures during follow-up. At four months,
according to a modified intent to treat analysis taking
into account the clustering effect, the decrease in
measured weight was greater in the standardised
consultation group than in the usual care group
(mean −1.11 (SD 2.49) kg v −0.37 (2.39) kg; P=0.007).
Theproportionofpatientswholostmorethan2kgwas
28.1% (41/146)in the standardisedconsultationgroup
and 16.0% (29/181) in the usual care group (P=0.01).
The increase in time spent on physical exercises as
measuredbythephysicalexerciseinleisuresubscaleof
the Baecke index was greater in the standardised
consultation group than in the usual care group (mean
0.20 (0.65) v 0.04 (0.78); P=0.013). When we applied
propensity methods in the primary analyses, the
differencesseenwerealsosignificant.Thestandardised
consultation and usual care groups did not differ in
secondary outcomes, except for pain (0-10 numerical
scale: mean −1.65 (2.32) v −1.18 (2.58); P=0.04) and
global assessment of disease activity (0-10 numerical
scale: mean −1.66 (2.26) v −0.90 (2.48); P=0.003). The
intraclustercorrelationcoefficientsvariedfrom0.00to
0.315 according to the outcome measure chosen and
are detailed in table 3.
Satisfaction
Atfourmonths,weevaluatedpatients’satisfactionwith
and knowledge of osteoarthritis of the knee and its
management for 272 patients. Patients in the
Table 3 |Mean change between baseline and four months for patients receiving standardised consultation and usual care
(n=327)
Mean SD
Intracluster correlation
coefficient (95% CI) P value* P value†
Weight (kg)
Standardised consultation −1.11 2.49 0.006 (0.000 to 0.144)
0.007 0.005
Usual care −0.37 2.39 0.000 (0.000 to 0.101)
PEL (0-5)
Standardised consultation 0.20 0.65 0.000 (0.000 to 0.357)
0.013 0.025
Usual care 0.04 0.78 0.244 (0.000 to 0.483)
Pain (NS 0-10)
Standardised consultation −1.65 2.32 0.315 (0.084 to 0.535)
0.041 0.020
Usual care −1.18 2.58 0.161 (0.000 to 0.383)
WOMAC physical function subscale (0-100)
Standardised consultation −5.74 10.66 0.079 (0.000 to 0.267)
0.199 0.121
Usual care −4.03 11.35 0.000 (0.000 to 0.184)
Global assessment of disease status (NS 0-10)
Standardised consultation −1.66 2.26 0.008 (0.000 to 0.298)
0.003 0.002
Usual care −0.90 2.48 0.281 (0.068 to 0.487)
Body mass index
Standardised consultation −0.37 1.14 0.069 (0.000 to 0.204)
0.124 0.095
Usual care −0.16 0.92 0.000 (0.000 to 0.116)
SF-12 physical function subscale (n= =276)
Standardised consultation 3.02 6.97 0.000 (0.000 to 0.200)
0.109 0.203
Usual care 1.83 7.39 0.001 (0.000 to 0.276)
SF-12 mental function subscale (n= =276)
Standardised consultation 0.36 8.91 0.000 (0.000 to 0.177)
0.890 0.665
Usual care 0.86 9.51 0.082 (0.000 to 0.286)
NS=numerical scale; PEL=physical exercises in leisure subscale of Baecke index; SF-12=Medical Outcomes Study short form 12; WOMAC=Western
Ontario and McMaster Universities osteoarthritis index.
*Comparisons were adjusted for baseline value and for baseline value of body mass index for all variables except weight.
†Comparisons were adjusted for baseline value and for baseline value of body mass index for all variables except weight and used a propensity score
weight method.
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those in the usual care group to have obtained
information about the need for regular exercises and
to lose weight and to have obtained documents on
osteoarthritis of the knee, exercise, and weight loss
(table 4). Their knowledge about management of
osteoarthritis of the knee did not differ substantially
fromthatoftheusualcaregroup,exceptforknowledge
about losing weight.
Adverse events
No adverse events were reported during the study.
One year follow-up
Atotalof235ofthe327patientsrandomisedagreedto
completetheoneyearfollow-upphoneinterview.The
standardised consultation and usual care groups did
not differ in self reported weight (mean −2.85 (4.76) v
−2.07 (4.37); P=0.20). The proportion of patients who
lost more than 2 kg was 44.5% (65/146) in the
standardised consultation group and 39.2% (71/181)
in the usual care group (P=0.36). The standardised
consultation group showed better scores than did the
usualcaregroupforphysicalactivity(mean0.23(0.72)
v 0.08 (0.85); P=0.024), pain level (n=145, mean −1.35
(2.48) v n=181, −0.86 (2.59); P=0.03), WOMAC
function score (n=144, mean −8.67 (12.05) v n=176,
−5.44 (12.97); P=0.02), global assessment of disease
activity (n=146, mean −1.40 (2.56) v n=181, −0.51
(2.59); P<0.001) and SF-12 physical component score
(n=129, mean 5.23 (8.18) v n=147, 2.97 (7.72);
P=0.003).
DISCUSSION
The results from this large, pragmatic, community
based cluster randomised controlled trial show that
with a programme of standardised consultations given
byrheumatologiststopatientswithosteoarthritisofthe
knee such patients can reduce their body weight,
increase the time they spend on physical activity, and
show improved pain level and global measures of
disease activity at four monthscomparedwith patients
given usual care. However, disability at four months
did not differ between the groups. At 12 months, the
twogroupsdidnotdifferinselfreportedweight,butthe
standardised consultation group showed greater
improvement in physical activities, pain level, and
function than did the usual care group.
Specific interventions aimed to increase physical
activities, decrease weight, or improve patients’
education about osteoarthritis have shown efficacy.
33
Exercisehasbeenshowntoimprovepainandphysical
function among people with osteoarthritis of the
knee.
34-37However,moststudiesevaluatingtheimpact
of these beneficial non-drug treatments have focused
on the efficacy of a single component. The overall
successofahealthcareprogrammeisseparatefromthat
ofitsindividualcomponents.Themaincontributionof
Table 4 |Patients’ knowledge about osteoarthritis and care and satisfaction with knowledge. Values are numbers (percentages)
unless stated otherwise
All patients
(n=272)
Standardised consultation
(n=126)
Usual care
(n=146) P value
Information obtained on (yes)
Knee osteoarthritis 223 (82.0) 108 (85.7) 115 (78.8) 0.117
Drug treatments 153 (56.2) 75 (59.5) 78 (53.4) 0.322
Need for regular exercise 212 (77.9) 117 (92.9) 95 (65.1) <0.001
Need to lose weight 227 (83.5) 116 (92.1) 111 (76.0) 0.001
Level of satisfaction related to the information obtained (very satisfied)
Knee osteoarthritis (n=223) 72/223 (32.3) 41/108 (38.0) 31/115 (27.0) 0.299
Drug treatments (n=155) 49/155 (31.6) 22/75 (29.3) 27/80 (33.7) 0.579
Need for regular exercise
(n=213)
86/213 (40.4) 50/117 (42.7) 36/96 (37.5) 0.574
Need to lose weight (n=229) 97/229 (42.4) 53/116 (45.7) 44/113 (38.9) 0.252
Documents obtained on (yes)
Knee osteoarthritis 139 (51.1) 99 (78.6) 40 (27.4) <0.001
Exercise 106 (39.0) 93 (73.8) 13 (8.9) <0.001
Weight loss 102 (37.5) 80 (63.5) 22 (15.1) <0.001
Patients’’ knowledge assessment
Exercise is always bad for knee
osteoarthritis (wrong)
172/271 (63.5) 89 (70.6) 83/145 (57.2) 0.024
Walking, cycling, or swimming
is good for knee osteoarthritis
(right)
224/271 (82.7) 109 (86.5) 115/145 (79.3) 0.132
Knee osteoarthritis is not
related to weight (wrong)
165/271 (60.9) 82 (65.1) 83/145 (57.2) 0.201
Losingweightcanimproveknee
osteoarthritis (right)
231/271 (85.2) 114 (90.5) 117/145 (80.7) 0.031
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the implementation of counselling about lifestyle
changes for patients with osteoarthritis.
Our results have high applicability because we
recruited rheumatologists in primary care settings, the
inclusion and exclusion criteria were not too stringent,
and the intervention, although complex, is easy to
reproduce. However, these results occurred in the
French healthcare system, in which patients have direct
access to rheumatologists, and we cannot exclude that
they may be different in other systems of care. In other
fields,suchinterventionsareoftendonebynursesrather
than physicians. Nurses could help physicians to do this
intervention, although the prime effect of advice from a
physician as a catalyst for changing patients’ behaviour
should not be underestimated.
38
In trials assessing participative interventions such as
education, physiotherapy, and counselling, the risk of
contamination is high if physicians do both inter-
ventions. One physician cannot counsel one patient to
lose weight and take physical exercise and not counsel
others in a similar way. Consequently, the use of a
cluster randomised controlled trial design avoids
contamination.Inclusterrandomisedcontrolledtrials,
observations for individual participants in the same
cluster tend to be correlated. We controlled for the
effect of clusters in the sample size calculation and
statistical analyses. Nevertheless, such a trial implies
risk of selection bias because, for our trial, we
randomised rheumatologists to trial arms before they
includedpatients,andtheywereconsequentlyawareof
the treatment they had to provide to the included
patients. Knowledge of assignment could lead to the
exclusion of certain patients depending on their
prognosis because they could have been allocated to
the perceived inappropriate group.
3940 Therefore, we
used propensity scores to deal with potential confoun-
ders and imbalance to confirm our results.
Achallengeinassessingnon-drugtreatmentsisrelated
todifficultiesofblinding.Tolimittheriskofbias,patients
were blinded to the study hypothesis (that is, they were
notinformedofthecontentofthetreatmentprovidedin
the other group), as has been proposed in other trials.
41
Furthermore,patientsineacharmhadthesamenumber
of visits. Consequently, the control arm is not really a
“usualcare”arm,becausethefollow-upofpatientsinthe
usualcareandstandardisedconsultationgroupsdiffered
greatlyfromtheusualcarecurrentlyprovidedtopatients
with osteoarthritis in France. Usually, patients with
osteoarthritis visit their rheumatologists every six or
12 months. This modification in visits could favour the
usual care group and potentially underestimate the
treatment effect. In the same way, the effects of the
intervention could have been reduced in part because
the percentage of patients in the control group who said
theyreceivedinformationaboutexercisewasveryhigh.
Intermsofclinicalrelevanceofthemodificationswe
saw, the mean weight reduction at four months was
limited(approximately1kg).However,someconsider
thata1kgweightlossisassociatedwitha4kgreduction
in knee load per step.
42 Therefore, for a person who
loses 1 kg in weight, each knee would be subjected to
4800 kg less in compressive load for each mile walked
(assuming1.2 strides/mile).
42Inaddition, we foundno
difference in patients’ self reported weight loss at one
yearbutasignificantimprovementinpainandphysical
function. Such improvement in a large population of
patients could have public health implications.
43
Thisstudyhasseverallimitations.Firstly,wedidnot
achieve the expected sample size because of logistic
difficultiesinrecruitingrheumatologists.However,our
significant differences and the risk of false positive
resultsarereducedbecausethestandarddeviationsand
intracluster correlation coefficients seen were lower
thanthevaluesassumedforthesamplesizecalculation.
Secondly,theclusterrandomisedcontrolleddesignwe
chosemayhaveimpliedbaselinedifferences,whichare
a particularconcern in such trials. Thebaselinedata of
patients showed a higher mean weight for the
standardised consultation than for the usual care
group. To take this into account, we did marginal
model analyses adjusted for baseline values, as well as
propensity score analysis. Thirdly, we excluded nine
randomised patients from the analysis because we did
not have any data (even baselinedata) for them, which
precluded any analysis or adjustment. The fourth
limitation is the partial lack of blinding, and we cannot
exclude the possibility that subjective outcomes could
be influenced despite our attempt to limit the risk of
bias by blinding the patients to the study hypothesis.
Conclusions
Our study shows that rheumatologists offering a
programme of standardised consultations about non-
drug treatment for osteoarthritis of the knee could be
usefulforpatientswithosteoarthritisoftheknee.Sucha
programme led to weight loss, increased physical
activity, and improved pain after four months and
improvedpatients’physicalactivity,pain,andfunction
atoneyear.Thisprogrammeofstandardisedconsulta-
tion should help rheumatologists to follow inter-
national guidelines for care of patients with
WHAT IS ALREADY KNOWN ON THIS TOPIC
Non-drugtreatments,includingeducationofpatients,social
support, physical exercises, and weight loss, are widely
recommendedformanagementofosteoarthritisoftheknee
However, such non-drug treatments are rarely proposed to
patients in clinical practice
The lack of implementation of these guidelines may be
linked to difficulties in providing information to patients on
all these important matters during a single consultation
WHAT THIS STUDY ADDS
A programme of three goal oriented standardised
consultations was useful for patients with osteoarthritis of
the knee
This programme led to increased weight loss and physical
activity atfour monthsand improved patients’ function and
pain at four months and at one year
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settings are needed to confirm these results.
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